Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions

Published:2008-02-26 Issue:1 Volume:9 Page:23-33
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Nelson M R,Bacanu S-A,Mosteller M,Li L,Bowman C E,Roses A D,Lai E H,Ehm M G

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

http://www.nature.com/articles/tpj20084.pdf

Reference42 articles.

1. Edwards IR, Aronson JK . Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356: 1255–1259.

2. Dimasi JA . Risks in new drug development: approval success rates for investigational drugs. Clin Pharmacol Ther 2001; 69: 297–307.

3. Wysowski DK, Swartz L . Adverse drug event surveillance and drug withdrawals in the United States, 1969–2002: the importance of reporting suspected reactions. Arch Intern Med 2005; 165: 1363–1369.

4. Lazarou J, Pomeranz BH, Corey PN . Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200–1205.

5. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329: 15–19.

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Pharmacogenomics in Rare Diseases;Drug Safety;2024-03-14

2. The clinical application of genetic testing in DILI, are we there yet?;Clinical Liver Disease;2024-01

3. Clinical investigation for the mechanisms of anaphylactic symptoms in osteoarthritis patients after diclofenac etalhyaluronate administration;Modern Rheumatology;2023-10-20

4. An association study of HLA with levofloxacin-induced severe cutaneous adverse drug reactions in Han Chinese;iScience;2023-08

5. Genetics of drug‐induced liver injury: Current knowledge and future prospects;Clinical and Translational Science;2022-10-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3